IntelGenx Technologies Corp. announced that Mark Nawacki has accepted his appointment by the Board of Directors to serve as a its director until the next annual meeting of the shareholders of the company or until his successor is duly elected and qualified. Nawacki is currently the President and CEO of Searchlight Pharma Inc. Prior to joining Searchlight Pharma, Nawacki spent over 11 years building out the commercial and geographic footprint of Paladin Labs, having served until September 2014 as Executive Vice President, Business and Corporate Development.